Literature DB >> 21091536

Clinical and experimental links between diabetes and glaucoma.

Vickie H Y Wong1, Bang V Bui, Algis J Vingrys.   

Abstract

Glaucoma is a leading cause of blindness. It is a multifactorial condition, the risk factors for which are increasingly well defined from large-scale epidemiological studies. One risk factor that remains controversial is the presence of diabetes. It has been proposed that diabetic eyes are at greater risk of injury from external stressors, such as elevated intraocular pressure. Alternatively, diabetes may cause ganglion cell loss, which becomes additive to a glaucomatous ganglion cell injury. Several clinical trials have considered whether a link exists between diabetes and glaucoma. In this review, we outline these studies and consider the causes for their lack of concordant findings. We also review the biochemical and cellular similarities between the two conditions. Moreover, we review the available literature that attempts to answer the question of whether the presence of diabetes increases the risk of developing glaucoma. At present, laboratory studies provide robust evidence for an association between diabetes and glaucoma.
© 2010 The Authors. Clinical and Experimental Optometry © 2010 Optometrists Association Australia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091536     DOI: 10.1111/j.1444-0938.2010.00546.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  26 in total

1.  Relationship Between Fuchs Endothelial Corneal Dystrophy Severity and Glaucoma and/or Ocular Hypertension.

Authors:  Mehul Nagarsheth; Annapurna Singh; Brian Schmotzer; Denise C Babineau; Joel Sugar; W Barry Lee; Sudha K Iyengar; Jonathan H Lass
Journal:  Arch Ophthalmol       Date:  2012-11

2.  Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients.

Authors:  Huiyuan Hou; Takuhei Shoji; Linda M Zangwill; Sasan Moghimi; Luke J Saunders; Kyle Hasenstab; Elham Ghahari; Patricia Isabel C Manalastas; Tadamichi Akagi; Mark Christopher; Rafaella C Penteado; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2018-02-13       Impact factor: 5.258

Review 3.  Presence and Risk Factors for Glaucoma in Patients with Diabetes.

Authors:  Brian J Song; Lloyd Paul Aiello; Louis R Pasquale
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

4.  Genome-wide genetic interaction analysis of glaucoma using expert knowledge derived from human phenotype networks.

Authors:  Ting Hu; Christian Darabos; Maria E Cricco; Emily Kong; Jason H Moore
Journal:  Pac Symp Biocomput       Date:  2015

5.  Neovascular glaucoma regulation by arylsulfonyl indoline-benzamide (ASIB) through targeting NF-kB signalling pathway.

Authors:  Xiaojun Lei; Yongxia Zhao
Journal:  3 Biotech       Date:  2019-05-10       Impact factor: 2.406

6.  Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease.

Authors:  Ivy S Samuels; Chieh-Allen Lee; J Mark Petrash; Neal S Peachey; Timothy S Kern
Journal:  Vis Neurosci       Date:  2012-10-29       Impact factor: 3.241

7.  A histopathological investigation of Tenon's capsule in diabetic eyes.

Authors:  Yasemin Ozdamar Erol; Pergin Atilla; Golge Acaroglu; Sevda Muftuoglu; Jale Karakaya
Journal:  Int Ophthalmol       Date:  2016-08-11       Impact factor: 2.031

Review 8.  Myopia and diabetes mellitus as modificatory factors of glaucomatous optic neuropathy.

Authors:  Etsuo Chihara
Journal:  Jpn J Ophthalmol       Date:  2013-08-15       Impact factor: 2.447

9.  Electroretinography in streptozotocin diabetic rats following acute intraocular pressure elevation.

Authors:  Kenichi Kohzaki; Algis J Vingrys; James A Armitage; Bang V Bui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-24       Impact factor: 3.117

10.  Intraocular pressure fluctuation and neurodegeneration in the diabetic rat retina.

Authors:  Kyoung In Jung; Jung Eun Woo; Chan Kee Park
Journal:  Br J Pharmacol       Date:  2020-04-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.